Launch Into Market With Real-World Evidence

August 22, 2017

Share this Flipbook
Facebook
Twitter
Email
LinkedIn
Google+

Even though you’ve satisfied regulators’ quality, safety and efficacy concerns, you may still have a hard time on the market because you haven’t proven value for payers. Follow this market launch countdown to help ensure you collect the data you need to get there.

Previous Flipbook

New Stakeholders, New Opportunities: How to Engage External Partners to Gain Market Access

Find out how to develop timely communication strategies here!

Next Flipbook

Real-World Data Strategies

Find out what payers are most concerned about in this article!

Most Recent Flipbooks

PAN EUROPEAN HTA - Where have we been, where are we going?

Launch Into Market With Real-World Evidence

Previous Flipbook

Next Flipbook

Most Recent Flipbooks

Creating aligned and integrated physician and payer-focused value propositions

This article will introduce some of the key factors and considerations for a successful evidence generation plan with further articles presenting additional details on specific components of the EGP.

This topical article examines the role of the CRO in using culturally specific strategies to engage under-represented patient populations, in order to boost trial recruitment.

Presentation from the Medical Affairs Leaders Forum, London. February 27 - March 01, 2018

This article looks at some of the trends in biosimilars, including three key errors you need to avoid. Particularly, as it pertains to underestimating your risk management plan.

Ian Kovacs, Head of QPPV & Safety Consulting at PAREXEL answers five key questions about the key role of a QPPV and why you should consider outsourcing.